Search For "clinical"
Drug regulator gets committee approval for nod to clinical trials by Serum
Updated : 5 years, 7 months ago IST
New Delhi [India], July 31 (ANI): The Subject Expert Committee at Central Drugs Standard Control Organisation (CDSCO) has recommended to the top drug regulator to grant permission to Serum Institute of India (SII) to conduct phase two and three clinical trials in India on a potential COVID-1
Read More
COVID-19 vaccine development: Only 3 vaccine candidates in phase III acros
Updated : 5 years, 7 months ago IST
New Delhi [India], July 30 (ANI): In the development related to the COVID-19 vaccine across the world, only three vaccine candidates are in phase III clinical trials across the globe. These three coronavirus vaccine candidates are from the USA, UK (University of Oxford's vaccine) and Chin
Read More
Drug Regulator asks Serum Institute to furnish revised protocol for COVID-
Updated : 5 years, 7 months ago IST
New Delhi [India], July 29 (ANI): The Central Drugs Standard Control Organisation (CDSCO) has advised the Serum Institute of India (SII) to submit a revised protocol to perform the clinical trials in India for potential COVID-19 vaccine.
Read More
Text messaging shows potential as therapy in treating mental health
Updated : 5 years, 7 months ago IST
Washington D.C. [USA], July 29 (ANI): A text-messaging intervention, on top of normal care, can be a safe, clinically promising, feasible tool to provide support to people with serious mental illness, according to a new study.
Read More
COVID-19: Health Ministry directs DCGI to ensure equitable distribution of
Updated : 5 years, 7 months ago IST
New Delhi [India], July 29 (ANI): The Union Health and Family Welfare Ministry has directed the Drugs Controller General of India (DCGI) to ensure equitable distribution of drugs across the country included as part of "investigational therapies" in clinical management protocol for COVID-19.
Read More
Domestic pharma giant SII applies to DCGI for phase 2/3 clinical trial of
Updated : 5 years, 8 months ago IST
New Delhi [India], July 25 (ANI): In a development related to the COVID-19 vaccine, the Serum Institute of India (SII) has applied to the Drugs Controller General of India (DCGI) for conducting the Phase 2/3 human clinical trials for a potential coronavirus vaccine.
Read More
Centre asks 9 states with high active COVID-19 caseload to strictly implem
Updated : 5 years, 8 months ago IST
New Delhi [India], July 24 (ANI): Cabinet Secretary Rajiv Gauba on Friday reviewed the management of COVID-19 in nine states with the high active caseload and asked them to urgently ramp up testing, augment health infrastructure and ensure effective clinical management.
Read More
COVID-19: AIIMS administers first dose of COVID-19 candidate vaccine `Cova
Updated : 5 years, 8 months ago IST
New Delhi [India], July 24 (ANI): The All India Institute of Medical Sciences (AIIMS) on Friday administered the first dose of country's first indigenous vaccine candidate `Covaxin' to a 30-year-old man as part of efforts to combat COVID-19.
Read More
Glenmark announces top-line results from phase 3 clinical trial of Favipir
Updated : 5 years, 8 months ago IST
Mumbai (Maharashtra) [India] July 23 (ANI/PRNewswire): Glenmark Pharmaceuticals Ltd - a global research-led pharmaceutical company - announced top-line results from a phase 3 clinical trial in mild to moderate COVID-19 patients, conducted across seven clinical sites in India.
Read More
COVID-19: Glenmark's Favipiravir drug shows encouraging results in Phase 3
Updated : 5 years, 8 months ago IST
New Delhi [India], July 22 (ANI): Domestic pharma giant Glenmark pharmaceuticals on Thursday announced the positive outcomes from a Phase 3 clinical trial conducted across seven clinical sites in India, where COVID-19 patients administered with Favipiravir reported faster clinical cure an
Read More
Delhi-based Dr. Dang's lab partners with Bharat Biotech for human clinical
Updated : 5 years, 8 months ago IST
New Delhi [India], July 22 (ANI): Delhi-based Dr. Dangs Lab has been selected to partner with Hyderabad-based Bharat Biotech for the human clinical trials of Covaxin, India's indigenous COVID-19 vaccine.
Read More
AIIMS to start best practices sessions for doctors across India on COVID-1
Updated : 5 years, 8 months ago IST
New Delhi [India], July 21 (ANI): The All India Institute of Medical Sciences (AIIMS), Delhi in collaboration with Union Health Ministry and NITI Aayog is all set to start a national programme called --"National Clinical Grandrounds on COVID-19" from Wednesday.
Read More